SCHEMBL24590122

SCHEMBL24590122

CCN(C)c1ccc2c(C)c(CCNC(C)=O)c(=O)oc2c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.54
▸ ALDH1A1 P00352 7/20 0.54
▸ GLA P06280 5/20 0.54
▸ GAA P10253 4/20 0.54
▸ ATM Q13315 3/20 0.54
▸ KLK7 P49862 1/20 0.54
▸ HSD17B10 Q99714 5/20 0.51
▸ CASP1 P29466 4/20 0.51
▸ CASP7 P55210 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ HTT P42858 2/20 0.51
▸ THRB P10828 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ IGLV6-57 P01721 8/20 0.51
▸ SRC P12931 2/20 0.50
▸ HSD17B3 P37058 1/20 0.48
▸ HPGD P15428 5/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24590109 0.90 ALDH1A1 (0.67) KDM4EALDH1A1GLAGAAATM
SCHEMBL22501642 0.82 KDM4E (0.69) KDM4EALDH1A1GLAGAAATM
SCHEMBL24590329 0.80 KDM4E (0.66) KDM4EALDH1A1GLAGAAATM
SCHEMBL22501670 0.80 IGLV6-57 (0.65) KDM4EALDH1A1GLAGAAATM
SCHEMBL22501629 0.80 ALDH1A1 (0.65) KDM4EALDH1A1GLAGAAATM
SCHEMBL24590073 0.76 IGLV6-57 (0.61) KDM4EALDH1A1GLAGAAATM
SCHEMBL24590074 0.76 KDM4E (0.59) KDM4EALDH1A1GLAGAAATM
SCHEMBL22501767 0.75 MAPT (0.68) KDM4EALDH1A1GLAGAAATM
SCHEMBL24589957 0.75 IGLV6-57 (0.74) KDM4EALDH1A1GLAGAAATM
SCHEMBL24590314 0.74 KDM4E (0.60) KDM4EALDH1A1GLAGAAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 KDM4E 4575/4885ALDH1A1 2072/4885GLA 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback